Ontak and dyspnoea Patient Reports February 10, 2010

Ontak Side Effects Report #5663754-2
Ontak side effect was reported by a Physician from UNITED STATES on Feb 25, 2008. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Ontak. After drug was administered, patient experienced the following side effects: dyspnoea, fatigue, leukopenia, neutropenia, thrombocytopenia. Ontak dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, PLAVIX, TOPROL, ASPIRIN. Patient recovered.

Ontak Side Effects Report #5723492-4
Ontak side effect was reported by a Physician from UNITED STATES on Aug 02, 2007. Male patient, 55 years of age, was diagnosed with mycosis fungoides and was treated with Ontak. After drug was administered, patient experienced the following side effects: angiopathy, chills, dyspnoea, pyrexia. Ontak dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, PREDNISONE, CYTOXAN, NEULASTA. Patient was hospitalized. Patient recovered.

Ontak Side Effects Report #5586199-2
Ontak side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2007. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: back pain , bradycardia, cardio-respiratory arrest, dyspnoea, fatigue, musculoskeletal pain, pain in extremity, pain in jaw, sinus tachycardia. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 12/19/2007.

Ontak Side Effects Report #5599265-2
Ontak side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: bradycardia, cardio-respiratory arrest, dyspnoea, fatigue, musculoskeletal pain, sinus tachycardia, unresponsive to stimuli. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.


Ontak Side Effects Report #5663755-4
Ontak side effect was reported by a Physician from UNITED STATES on Feb 28, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: asthenia, bradycardia, cardio-respiratory arrest, cardiomegaly, dyspnoea, electromechanical dissociation, malaise, nausea , pain . Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.

Ontak Side Effects Report #5710514-X
Ontak side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, back pain , blood creatine phosphokinase increased, blood glucose increased, cardio-respiratory arrest, cardiomegaly, dyspnoea, electromechanical dissociation. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.